These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 17785205)

  • 1. LZAP, a putative tumor suppressor, selectively inhibits NF-kappaB.
    Wang J; An H; Mayo MW; Baldwin AS; Yarbrough WG
    Cancer Cell; 2007 Sep; 12(3):239-51. PubMed ID: 17785205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear factor-kappaB is an important modulator of the altered gene expression profile and malignant phenotype in squamous cell carcinoma.
    Loercher A; Lee TL; Ricker JL; Howard A; Geoghegen J; Chen Z; Sunwoo JB; Sitcheran R; Chuang EY; Mitchell JB; Baldwin AS; Van Waes C
    Cancer Res; 2004 Sep; 64(18):6511-23. PubMed ID: 15374962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression levels of nuclear factor kappa B and gelatinases in the tumorigenesis of oral squamous cell carcinoma.
    Bindhu OS; Ramadas K; Sebastian P; Pillai MR
    Head Neck; 2006 Oct; 28(10):916-25. PubMed ID: 16823875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cepharanthin-enhanced radiosensitivity through the inhibition of radiation-induced nuclear factor-kappaB activity in human oral squamous cell carcinoma cells.
    Tamatani T; Azuma M; Motegi K; Takamaru N; Kawashima Y; Bando T
    Int J Oncol; 2007 Oct; 31(4):761-8. PubMed ID: 17786306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdelta-mediated signaling in MCF-7 human breast cancer cells.
    Park SK; Hwang YS; Park KK; Park HJ; Seo JY; Chung WY
    Carcinogenesis; 2009 Jul; 30(7):1225-33. PubMed ID: 19420016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigallocatechin-3-gallate, a histone acetyltransferase inhibitor, inhibits EBV-induced B lymphocyte transformation via suppression of RelA acetylation.
    Choi KC; Jung MG; Lee YH; Yoon JC; Kwon SH; Kang HB; Kim MJ; Cha JH; Kim YJ; Jun WJ; Lee JM; Yoon HG
    Cancer Res; 2009 Jan; 69(2):583-92. PubMed ID: 19147572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Berberine modifies cysteine 179 of IkappaBalpha kinase, suppresses nuclear factor-kappaB-regulated antiapoptotic gene products, and potentiates apoptosis.
    Pandey MK; Sung B; Kunnumakkara AB; Sethi G; Chaturvedi MM; Aggarwal BB
    Cancer Res; 2008 Jul; 68(13):5370-9. PubMed ID: 18593939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of NF-kappaB activity by NDRG2 expression attenuates the invasive potential of highly malignant tumor cells.
    Kim A; Kim MJ; Yang Y; Kim JW; Yeom YI; Lim JS
    Carcinogenesis; 2009 Jun; 30(6):927-36. PubMed ID: 19336468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-8 expression is regulated by histone deacetylases through the nuclear factor-kappaB pathway in breast cancer.
    Chavey C; Mühlbauer M; Bossard C; Freund A; Durand S; Jorgensen C; Jobin C; Lazennec G
    Mol Pharmacol; 2008 Nov; 74(5):1359-66. PubMed ID: 18669446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hesperidin inhibited acetaldehyde-induced matrix metalloproteinase-9 gene expression in human hepatocellular carcinoma cells.
    Yeh MH; Kao ST; Hung CM; Liu CJ; Lee KH; Yeh CC
    Toxicol Lett; 2009 Feb; 184(3):204-10. PubMed ID: 19110045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The LIM-homeodomain transcription factor LMX1B regulates expression of NF-kappa B target genes.
    Rascle A; Neumann T; Raschta AS; Neumann A; Heining E; Kastner J; Witzgall R
    Exp Cell Res; 2009 Jan; 315(1):76-96. PubMed ID: 18996370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of activated nuclear factor-kappaB in the pathogenesis and therapy of squamous cell carcinoma of the head and neck.
    Allen CT; Ricker JL; Chen Z; Van Waes C
    Head Neck; 2007 Oct; 29(10):959-71. PubMed ID: 17405170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HDAC2 deficiency sensitizes colon cancer cells to TNFalpha-induced apoptosis through inhibition of NF-kappaB activity.
    Kaler P; Sasazuki T; Shirasawa S; Augenlicht L; Klampfer L
    Exp Cell Res; 2008 Apr; 314(7):1507-18. PubMed ID: 18314102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decrease in RelA phosphorylation by inhibiting protein kinase A induces cell death in NF-kappaB-expressing and drug-resistant tumor cells.
    Manna SK; Gangadharan C
    Mol Immunol; 2009 Apr; 46(7):1340-50. PubMed ID: 19128834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein kinase Cdelta activates RelA/p65 and nuclear factor-kappaB signaling in response to tumor necrosis factor-alpha.
    Lu ZG; Liu H; Yamaguchi T; Miki Y; Yoshida K
    Cancer Res; 2009 Jul; 69(14):5927-35. PubMed ID: 19549902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ursolic acid inhibits IL-1beta or TNF-alpha-induced C6 glioma invasion through suppressing the association ZIP/p62 with PKC-zeta and downregulating the MMP-9 expression.
    Huang HC; Huang CY; Lin-Shiau SY; Lin JK
    Mol Carcinog; 2009 Jun; 48(6):517-31. PubMed ID: 18973186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wnt/beta-catenin signaling regulates cytokine-induced human inducible nitric oxide synthase expression by inhibiting nuclear factor-kappaB activation in cancer cells.
    Du Q; Zhang X; Cardinal J; Cao Z; Guo Z; Shao L; Geller DA
    Cancer Res; 2009 May; 69(9):3764-71. PubMed ID: 19383900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of CYLD might be associated with development of salivary gland tumors.
    Fukuda M; Hiroi M; Suzuki S; Ohmori Y; Sakashita H
    Oncol Rep; 2008 Jun; 19(6):1421-7. PubMed ID: 18497946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NF-kappaB: tumor promoter or suppressor?
    Perkins ND
    Trends Cell Biol; 2004 Feb; 14(2):64-9. PubMed ID: 15102437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wild-type p53 inhibits nuclear factor-kappaB-induced matrix metalloproteinase-9 promoter activation: implications for soft tissue sarcoma growth and metastasis.
    Liu J; Zhan M; Hannay JA; Das P; Bolshakov SV; Kotilingam D; Yu D; Lazar AF; Pollock RE; Lev D
    Mol Cancer Res; 2006 Nov; 4(11):803-10. PubMed ID: 17077165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.